TY  - JOUR
AU  - Kaluđerović, Goran N.
AU  - Dinovic, Vesna M.
AU  - Juranić, Zorica D.
AU  - Stanojković, Tatjana
AU  - Sabo, Tibor
PY  - 2006
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/780
AB  - Cisplatin analogues, cis-dichloro(ethylenediamine-N,N'-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N'-di-3-propanoic acid) platinum(II) (2), as well as trans-dichloro(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N'-diacetato)platinum(IV) (5) and trans-dibromo(propylenediamine-N,N'-diacetato)platinum(IV) (6), -([Pt(H(2)eddp)Cl(2)], [Pt(Heddp)I], trans-[Pt(eddp)Cl(2)], trans-[Pt(eddp)Br(2)], trans-[Pt(pdda)Cl(2)] and trans-[Pt(pdda)Br(2)], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin.
PB  - Taylor & Francis Ltd, Abingdon
T2  - Journal of Coordination Chemistry
T1  - Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells
VL  - 59
IS  - 7
SP  - 815
EP  - 819
DO  - 10.1080/00958970500404708
ER  - 

@article{
author = "Kaluđerović, Goran N. and Dinovic, Vesna M. and Juranić, Zorica D. and Stanojković, Tatjana and Sabo, Tibor",
year = "2006",
abstract = "Cisplatin analogues, cis-dichloro(ethylenediamine-N,N'-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N'-di-3-propanoic acid) platinum(II) (2), as well as trans-dichloro(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N'-diacetato)platinum(IV) (5) and trans-dibromo(propylenediamine-N,N'-diacetato)platinum(IV) (6), -([Pt(H(2)eddp)Cl(2)], [Pt(Heddp)I], trans-[Pt(eddp)Cl(2)], trans-[Pt(eddp)Br(2)], trans-[Pt(pdda)Cl(2)] and trans-[Pt(pdda)Br(2)], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin.",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Journal of Coordination Chemistry",
title = "Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells",
volume = "59",
number = "7",
pages = "815-819",
doi = "10.1080/00958970500404708"
}

Kaluđerović, G. N., Dinovic, V. M., Juranić, Z. D., Stanojković, T.,& Sabo, T.. (2006). Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells. in Journal of Coordination Chemistry
Taylor & Francis Ltd, Abingdon., 59(7), 815-819.
https://doi.org/10.1080/00958970500404708

Kaluđerović GN, Dinovic VM, Juranić ZD, Stanojković T, Sabo T. Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells. in Journal of Coordination Chemistry. 2006;59(7):815-819.
doi:10.1080/00958970500404708 .

Kaluđerović, Goran N., Dinovic, Vesna M., Juranić, Zorica D., Stanojković, Tatjana, Sabo, Tibor, "Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells" in Journal of Coordination Chemistry, 59, no. 7 (2006):815-819,
https://doi.org/10.1080/00958970500404708 . .